The Osurnia Ear Health Hub includes information about the treatment of canine otitis externa from dermatologists Sue Paterson and Natalie Barnard, advice about responsible antibiotic use, expert tips for vets to use in the consulting room and dog owner educational materials that veterinary staff can use in practice and online. It will also include a podcast interview with Sue.
The hub also provides information, videos and research about Osurnia.
Elanco Animal Health UK Marketing Manager, Rebecca Bryant said: "We know all too well the challenges vets face when treating canine OE and the significant impact the condition has on the quality of life of both the dog and the owner.
"The Osurnia Ear Health Hub is a new disease resource hub on MyElanco, which provides helpful resources for veterinary professionals looking for answers or to enhance their understanding of the disease. We hope that with more easily accessible information, this will help vets to treat OE cases and communicate with their clients."
Visit the canine ear health hub at: www.myelanco.co.uk
Whilst on the subject of information resources, this one has come to my attention. It's a list of other veterinary blogs and resources: https://blog.feedspot.com/veterinary_blogs.
Set up by veterinary surgeons, Animal Trust trumpets the fact that its main focus is on the welfare of animals. How that makes it different to any other practice in the country is hard to see, however Animal Trust also says that it reinvests all profits back into the business for the benefit of its patients.
Owen Monie, the founder of Animal Trust, said: "We couldn’t be prouder to be opening our second clinic in Yorkshire.
"The success of our Tingley clinic has increased demand across the county, therefore we identified the need of a not-for-profit veterinary clinic further west in Yorkshire."
"Unlike most veterinary clinics, we offer free consultations with experts to enable patients to access care and advice on treatment exactly when they need help."
No doubt the practice's charitable-sounding name and positioning will continue to grate others in the profession who also do so much pro-bono work.
Still, you've got to credit Dr Monie: it's a powerful consumer proposition he's got there.
Achieved by VMG members who have demonstrated an ability to effectively manage a veterinary practice, hospital or unit, the CVPM is aimed at experienced managers and members of the veterinary team in a leadership or management role. The qualification tests the knowledge of candidates in areas including management, HR, communication, marketing and financial planning.
VMG Director Georgina Hills (pictured right) said: "Effective veterinary leaders require expertise in all aspects of running a successful business, as well as a deep understanding of the veterinary sector and the CVPM is unique in testing their knowledge across the board. It is increasingly recognised as a benchmark for excellence and we are delighted to have seen an uplift in applications last year."
Further details on the CVPM and the application form are available here: https://www.vetmg.com/education/cvpm/
Bordetella bronchiseptica is a clinically significant pathogen for canine infectious respiratory disease (CIRD), otherwise known as kennel cough, with 78.7% of dogs with acute respiratory signs testing positive for the bacteria1.
In the same study, 45.6% of clinically healthy dogs also tested positive for Bordetella bronchiseptica, illustrating that clinically healthy dogs can carry respiratory pathogens and could act as sources of infection for susceptible dogs1.
Administered via subcutaneous injection, Canigen Bb is an inactivated subunit vaccine which offers vets a new option when intra-nasal vaccination with a live aerosolised vaccine is not possible or preferred, for example when the dog is in contact with known immunocompromised individuals.
Licensed for use in dogs from 6 weeks of age, Canigen Bb extends protection against Bordetella bronchiseptica in dogs vaccinated with Canigen KC in the last 12 months for a further year with a single dose.
Canigen Bb is presented as a ready-to-use formula in a 10ml multi-dose bottle and can be stored at room temperature (2°C - 25°C) for up to 4 weeks once broached.
It can be administered concurrently (at the same time but separate injections) with Canigen DHP, Canigen DHPPi, Canigen Pi & Canigen Lepto 4.
Andrew Connolly, Marketing Director at Virbac, said: ‘It is our hope that Canigen Bb will increase the overall uptake of Bordetella bronchiseptica vaccination to provide increased protection against this widely prevalent and clinically significant disease’.
Reference
The study was based on VetCompass anonymised clinical records from more than two million dogs under first opinion veterinary care in the UK in 2019.
The study applied causal inference methods to the analysis of random samples of 815 dogs with CCL rupture aged between 1.5- and 12-years-old to replicate a randomised clinical trial and explore the impact of the different treatment methods.
Balancing the arms of the study for variables including age, breed and bodyweight, the researchers compared the outcomes for the dogs who received surgical management for CCL ruptures to those that were managed non-surgically.
The results showed that dogs managed surgically were 25.7% less likely to show short-term lameness at 3 months post-diagnosis and 31.7% less likely to show long-term lameness at 12 months post-diagnosis than dogs managed non-surgically.
Surgically managed dogs were 38.9% less likely to have a pain relief prescription at 3 months post-diagnosis, 34.1% less likely at 6 months and 32.7% less likely at 12 months than dogs managed non-surgically.
The RVC says these findings also similarly demonstrate lower longer term pain in surgically managed dogs.
Camilla Pegram, VetCompass PhD student at the RVC and lead author of the paper, said: “This study used an exciting new approach that allowed us to determine ‘cause’ rather than being limited to ‘association’.
"Surgical management for CCL rupture is often considered as providing better outcomes than non-surgical management, but this study now provides an evidence base to support this.
"Whilst surgical management might not always be feasible for some dogs, the findings allow vets to quantify the benefit in their discussions with owners.”
https://doi.org/10.1016/j.prevetmed.2024.106165
The company says the reason for the change is so that it can dedicate additional resources to the business.
Samantha Williamson, UK Country Manager at Animalcare, said: "Through our identichip microchips and our identibase pet database, we provide one of the UK’s longest-established pet microchipping services and are helping to reunite owners with their lost pets every single day.
"The pet reunification sector is evolving rapidly thanks to technological advances. We believe that the creation of identicare will facilitate the concentration of resources and expert knowledge needed to fuel the growth in our identichip business and continued enhancements to the identibase pet database. identicare will share the same passion and values as Animalcare and there will be no outward change for our customers.
“We look forward to continuing to deliver our ambition of delivering the highest quality pet reunification service under the identicare banner.”
The new company is part of the Animalcare Group.
BCF Technology has launched a series of free canine X-ray positioning guides which are now available to download from www.bcftechnology.com.
The company says the guides are designed to provide a quick, easy-to-use reference to help you get the best radiographic views possible, every time.
BCF in-house radiographer Kat Evans said: "At BCF, we understand that capturing a great X-ray isn't just about having the best equipment; good positioning is crucial, these easy-to-use guides will help vets and vet nurses to create the very best radiograph."
BCF in-house vet Ben Sullivan added: "At BCF we are committed to improving the standards of radiography in the veterinary profession. We aim to help our customers make the very most of their equipment. This is why we are committed to supporting ongoing education and training. You will find a huge range of learning materials on our website aimed at helping you to develop further your veterinary ultrasonography and radiography abilities.
Full small animal and equine positional guides are in-built into the software of all CR X-ray systems available from BCF.
For more information, visit www.bcftechnology.com or call +44(0)1506 460 023.
The RCVS is looking to recruit two veterinary surgeons as part-time Postgraduate Deans, to help oversee new veterinary graduates during their Professional Development Phase (PDP).
Freda Andrews, RCVS Head of Education said: "The PDP is an online recording system to guide new graduates as they work towards achieving the "year one competences" - the competences expected of a new graduate who's had about a year's experience in practice. Postgraduate Deans monitor PDP participants' progress and respond to their queries, and ultimately sign-off the graduates once their PDP is complete."
The roles have become available as two of the current post-holders, Stephen Ware and Professor David Noakes, wish to hand over to new colleagues. Both Stephen and David have served as Postgraduate Deans since 2007, when the PDP first became a requirement for all new veterinary graduates.
Stephen said: "Being a Postgraduate Dean gives you the opportunity to assist new graduates in the early stages of their career. It is also a way to encourage employers to take a responsible attitude towards new vets, particularly during their first job or two."
Postgraduate Deans are expected to spend up to 20 days a year working mainly online from home, and attend occasional meetings at the RCVS in London. They need experience of general practice, and to be used to dealing with and advising students, or employing and supporting new graduates. A sympathetic understanding of the challenges faced by newly qualified veterinary graduates is also required.
Further information about the role can be found at www.rcvs.org.uk/jobs, and information about the PDP, including a preview, at www.rcvs.org.uk/pdp.
Applicants should send a brief CV, and a covering letter setting out their relevant experience, to education@rcvs.org.uk by 7 March 2011.
Game players have to 'catch' falling symbols marked with a '+' or the Credelio Plus ingredients, milbemycin oxime and lotilaner to win points, and avoid ones with fleas, ticks and worms, which lose points.
In addition to the £50 vouchers, there are goody packs for four runners up each month.
William Hawker, Parasiticides Marketing Manager at Elanco Animal Health said: "We are excited to showcase our novel new game at BVA Live with this exciting drop and offer all attendees the first chance to play Plus Plummet and win some great prizes by topping the leaderboard every month."
To play the game, visit: https://www.myelanco.co.uk/brand/plus-plummet
Incidentally, if you're at BVA Live, you're invited to join Elanco at the Exhibitor Showcase Theatre tomorrow from 09:00-09:50 for ‘Parasitology: Testing Times? Navigating the current challenges in practice’.
Cat Henstridge (BVSc MRCVS, small animal vet) will be interviewing Ian Wright (head of ESCCAP) and answering questions on everything from when to test, when to treat and how to communicate with pet owners about choice and the parasiticide treatment options available.
Photo: Elanco launches Plus Plummet at BVA Live
The programme includes a mix of online and in-person sessions hosted by Blaise's multi-disciplinary team.
Lara Dempsey, head of soft tissue surgery at the hospital, will start with ‘To close or not to close, that is the question’ on Monday 27th January.
Lara's online session will cover tips and tricks for open wound management and wound closure options, case studies and her preferred products to use in practice.
On Thursday 8th May, head of anaesthesia and analgesia Jacques Ferreira (pictured) will host a one-day workshop on pain management, taking place at Blaise.
Attendees will develop their understanding of acute and chronic pain, and the difference between them.
Jacques will also discuss the future of nerve blocks and share techniques that can be used in practice.
Julie Davis, hospital director at Blaise, said: “We have an incredible team here at Blaise and are very much looking forward to sharing our collective knowledge with colleagues from across the veterinary profession.
The full programme of free CPD events:
www.blaise-referrals.com/vet-hub/cpd-events
Her Majesty The Queen has today opened the University of Surrey's new £45m School of Veterinary Medicine, accompanied by His Royal Highness The Duke of Edinburgh.
Her Majesty and His Royal Highness toured the Large Animal Clinical Skills Building, where they met students taking equine examinations and working with livestock. The Royal Party also viewed a demonstration in the Biomechanics Laboratory, meeting Professor Noel Fitzpatrick and dogs that have benefitted from prosthetic limb surgery. They also watched teaching sessions in the Clinical Skills Laboratory, meeting staff and students.
After the tour, The Queen, The Duke and assembled guests attended a short ceremony to celebrate the opening of the new teaching facilities, during which Her Majesty unveiled a plaque to mark the occasion.
As The Royal Party left, they were bid farewell by Joey, the star of the theatre production War Horse.
Professor Michael Kearney, Vice-Chancellor of the University of Surrey, said: “We are hugely honoured to welcome Her Majesty and His Royal Highness to the University of Surrey. This is a very special occasion that tops off an exceptional start to the academic year for the University, after the launch of our 5G Innovation Centre and achieving The Times and Sunday Times ‘University of the Year’ accolade.
“The School of Veterinary Medicine further cements our position as a world-class institution that is delivering cutting-edge teaching and research from state-of-the-art facilities. It will not only provide the next generation of sought-after veterinary graduates, but it will offer significant opportunities for collaboration between human and animal medical science professionals and public sector organisations.”
Professor Noel Fitzpatrick, one of the founding partners of the School of Veterinary Medicine, said: “I had a vision where we would deliver a degree structure which was truly focussed on what you dream about when you are sixteen years old, when you are desperate to become a vet. I fully intend to be part of a team that will kindle that fire throughout professional life to shine a light onto the world that badly needs ambassadors of purpose and integrity to be the caretakers of health on Earth, both now and for long after I’m gone and these new buildings will still be standing. This is our legacy, and we are intensely proud to be part of this evolution in health education.”
Carl's article: 'Are you using a safety checklist in your practice?', focuses on the benefits of introducing a safety checklist in practice to reduce patient morbidity, mortality and to improve communication between members of the veterinary team.
He explains how a checklist helps eliminate the need to memorise every single step of a protocol and self-limit any errors that may eventually lead to a fatal or near-fatal incident, and how it should contain a limited number of elements, allow quick completion and most importantly be relevant to the situation.
The article includes information on how to introduce a safety checklist, steps to consider and how to use one in practice.
It also contains links to downloadable tools including the Association of Veterinary Anaesthetists (AVA) safety checklist and implementation booklet and information on the association’s ‘Safer Anaesthesia Project’. An editable safety checklist will also be available to download from the ‘Anaesthesia1ST’ blog that practices can adapt to their own requirements.
Richard Beckwith, country manager of Jurox (UK) said: "Our hugely popular Anaesthesia1ST newsletter features state-of-the-art, practical and easy to read articles to help veterinary professionals deliver 1ST class anaesthesia to all patients. Our latest edition will challenge practices to consider safety checklists as an essential part of their pre-anaesthetic routine in order to reduce the risk of mistakes."
To sign up to the Anaesthesia1ST newsletter visit the Alfaxan website – www.alfaxan.co.uk, contact your local Jurox technical sales representative or email Jurox at info@jurox.co.uk.
Eight dogs being treated at three veterinary clinics in Norway took part in the study1.
Previous research2 has found a complication rate of 55% when fibreglass casts are used, 20% of them severe. In this study using the Upets Splinting System, only 12.5% of dogs (n=1) had complications that required treatment, and the complications were minor.
Dassiet says the results suggest that the new product has the potential to make veterinary casting safer, more sustainable, and can help control costs associated with cast replacement and treatment of complications.
86% of the veterinary surgeons participating in the study rated the Upets Splinting System as easy to use and said they would use the product on their own dog.
An earlier poll3 questioned vets on their most common concerns about casting and identified that the most significant were fear of complications (57%), the time-consuming nature of casting (54%) and inconvenience (51 %).
Dr. Martin Kaufmann, OrthoPets founder and Dassiet VET COO, said: “Complications often result from a cast that does not fit as well as it should.
"The results of this study suggest that Upets might be the ground-breaking tool that veterinarians have been waiting for as it provides them with the means to achieve a cast shape that is more precise."
For the white paper detailing the trial, visit: www.upets.vet/research.
References
Dr Radev faced three charges concerning his treatment of an American Bulldog in 2021.
The first charge, which contained a number of sub-charges, was that he failed to provide appropriate and adequate care to the animal.
The second was that he failed to keep adequate records.
The final charge was that his failure to keep records was misleading and dishonest.
At the outset of the hearing Dr Radev admitted that, having recognised free fluid in the dog’s abdomen, he failed to take adequate and appropriate action and failed to aspirate the dog’s abdomen with regards to the possibility of it having septic peritonitis.
He also admitted writing the clinical notes approximately two months after the event.
After considering and rejecting an application by the RCVS to amend and withdraw elements of the first charge, the Committee then considered each of the remaining sub-charges in turn.
Sub-charge 1(a) was that Dr Radev repeatedly administered meloxicam to the dog when it had recently undergone intestinal surgery and had a recent history of vomiting.
The Committee found that this was not proven.
Dr Radev said it had been administered just once and the Committee was not satisfied so as to be sure that it was repeatedly administered.
Sub-charge 1(b) (i) was that Dr Radev failed to recognise free fluid in the dog’s abdomen as shown on an ultrasound scan.
The Committee found this not proven.
Sub-charge 1(c) (i) was that Dr Radev failed to recognise the possibility of septic peritonitis in the dog.
Sub-charge 1(e) was that Dr Radev failed to provide a full medical history when referring the dog to a different practice.
The Committee found the charge not proven.
Regarding charge 2 (ii), that Dr Radev had failed to include in clinical records a reference to the colonotomy surgery, the Committee found this charge not proven as it had been provided with clinical records disproving this charge.
Finally, regarding both aspects of charge 3, namely that Dr Radev had acted misleadingly and dishonesty, the Committee found this not proven.
The Committee then considered whether the charges that Dr Radev had admitted amounted to gross misconduct in a professional respect.
In all cases it found that, while Dr Radev’s conduct had fallen below what was expected of veterinary professionals, it did not fall so far below as to constitute serious professional misconduct.
www.rcvs.org.uk/disciplinary
Woodley Equipment Company has launched RapidVet-H IC a testing kit for identifying blood types in cats and dogs.
RapidVet-H IC uses immuno-chromatographic technology to identify the feline blood groups: Type A, Type B and Type AB, and the canine blood groups: DEA 1.1 Negative and DEA 1.1 Positive
According to Woodley, this is the first such system to present a positive result as a red line on a white background, thus making it very easy to read.
RapidVet-H IC consists of a hand-held device containing three membranes and uses a diluent specific for these tests. It uses whole blood, or packed red blood cells. It is a cell capture assay, so patients exhibiting auto-agglutination or low PCV can be typed. The system displays results in 5-10 minutes.
For more information about RapidVet-H IC, email: sales@woodleyequipment.com, or call Woodley on +44 (0) 1204 669033 Option 1.
Boehringer Ingelheim Vetmedica has added a cardiology CPD section to its Vetmedin website. The section also includes a number of owner education resources to be used in practice.
The site, which is billed as a one-stop-shop on canine heart disease, includes an interactive radiology viewer, the Vetmedin atlas of cardiac radiology, radiology interpretation and diagnosis, an interactive MVD seminar and online downloadable Vetmedin dosage calculator to assist veterinary surgeons in prescribing the optimum dose.
Owner education materials include an animation explaining how to monitor a dog's resting respiratory rate, a video about heart failure and downloadable charts to help owners monitor their dog's condition.
For further information, visit www.vetmedin.co.uk, contact your Boehringer Ingelheim Vetmedica territory manager or call 01344 746959.
Kruuse has launched two products for the treatment of digital dermatitis in cattle: the Bovivet hoof bandage and Kruuse Hoof Gel.
According to the company, an estimated that 70% of dairy herds suffer with digital dermatitis (DD), and it is a growing problem. If not treated, it can persist for months, causing pain and lameness to infected cows. As well as worrying animal welfare concerns, numerous studies have shown that the disease can have a direct impact on milk production and reproduction with financial implications for the dairy farmer.
Traditionally, treatment has involved thoroughly washing the infected hoof, applying an antibiotic/drying agent such as salicylic acid powder and then applying a dressing that must typically remain in place for three days. This method comes with its own problems, including the difficulty dosing salicyclic acid powder correctly, the risk to the user's health when mixing, and the difficulty ensuring that the dressing is correctly applied at the right pressure and that it stays in place.
To help overcome these problems, Kruuse has introduced two products. The first is the ready-to-apply Bovivet complete Hoof Bandage. It is made from a water-repelling material that keeps out unwanted liquids. Its shape and elasticity are designed to keep the bandage in place. Inside the bandage is a treatment pad that makes for easy dosing. The outer stocking design allows for checking on the progress of treatment and for re-application if necessary. The bandage is available in two sizes, large which fits most cattle breeds, and small for calves and small breeds.
The second product, to be used in conjunction with the Bovivet Hoof Bandage, is Kruuse Hoof Gel 38%, containing 38% salicyclic acid. Kruuse says that dosing with this gel product is easier and more accurate than with the powder, making it more economical per treatment. It also reduces potential health risks to the user from inhalation of the powder when mixing.
Kruuse has produced the following instructional video to demonstrate the new products' ease of use and versatility:
The NOAH Compendium is also available online at www.noahcompendium.co.uk. A special edition of the book for SQPs, commissioned by AMTRA, will be also available shortly.
NOAH chief executive Dawn Howard said: "The NOAH Compendium remains a major part of NOAH’s efforts to assist the appropriate and responsible use of all animal medicines.
"Every NOAH member, as well as the non-member participants in the NOAH Compendium, is a signatory to the NOAH Code of Practice on Promotion, which demonstrates their commitment to operate above and beyond any regulatory requirements.
"As always, our free of charge web-based Compendium, which is updated regularly, contains the most up-to-date information. If you have not been on the website lately you will see we have introduced a ‘Company Directory’ as well as ‘datasheets by company’, as well as improving the facility of the site to print individual datasheets.
Meanwhile, NOAH says the app version of the Compendium has been temporarily suspended while certain technical difficulties are resolved. Dawn said: "We have recently faced an unexpected issue with the NOAH Compendium App and have temporarily suspended the App’s availability on both the Apple store and Googleplay.
"The app is currently being updated and we are working to get it back online as soon as possible. If you have already downloaded the app, please note there will be no further updates to the information until we can resolve the issue, and the information it displays may not be the most recent update."
If your practice has not yet received its copy, perhaps because you are a new practice, or have changed address in the past year, contact Amy Davis at NOAH (a.davis@noah.co.uk).
Extra copies are also available to order now, for £46. Special prices are available for bulk orders.
It's a subject that will be front of many people's minds following the recent cases of equine flu.
As part of the campaign, MSD has produced a range of veterinary practice support materials to help you engage with owners and yards on the subject of preventative healthcare best practice and compliance.
The range includes shareable social media content, videos, a 'What's Your Risk' practice poster, an online risk assessment tool and a number of downloadable information leaflets. Practices will also be supported through the Keep Britain's Horses Health (KBHH) web page, Facebook page and Twitter.
MSD says there are also planning and evaluation resources to help practices manage an effective campaign.
Vicki Farr, Equine Veterinary Advisor at MSD Animal Health said: "The recent outbreaks of equine flu have rocked the horse-racing world, costing the industry millions and raising important animal welfare issues. Furthermore, they have highlighted the need for good preventative healthcare and, in particular, vaccination.
"HHW will therefore come at a relevant time for horse owners and yards when the impact of equine flu is still at the front of their minds.
"This year HHW will provide vital tools for practices; building on the knowledge and resources we’ve acquired throughout the KBHH campaign and from previous HHWs.
"Our focus is on engaging owners and yards on understanding the risk of disease for their horse, while rewarding them for best practice. We are again providing a wide range of resources for practices to help them create an engaging and successful campaign that helps build knowledge amongst the equine community."
For further information, talk to your MSD Animal Health Equine Account Manager, call 01908 685685 or refer to KBHH social media feeds on Facebook page and Twitter (@keepinghorseshealthy).
The RCVS announced in a tweet yesterday afternoon that it will be retaining postnominals on the Register.
#RCVScouncil agrees to retain postnominals on Register. Proposals to improve clarity to come back to future meeting. — RCVS (@RCVS_UK) June 5, 2014
#RCVScouncil agrees to retain postnominals on Register. Proposals to improve clarity to come back to future meeting.
VetSurgeon understands that the proposals to improve clarity may yet involve some rationalisation of the postnominals that will be displayed, but that RCVS Certs and Diplomas will remain.
The decision represents something of a victory for Victoria Lilley’s campaign and yet another indication that under the stewardship of Nick Stace, the RCVS really is evolving to become a more open, responsive organisation.
Velactis (cabergoline) is a POM marketed by Ceva Animal Health, used in the herd management programme of dairy cows as an aid in abrupt drying-off, by reducing milk production.
The product was authorised through the European Medicines Agency (EMA) in December 2015 and was first sold in the UK in April 2016.
The VMD says it has been made aware of reports of serious adverse events, predominantly occurring in Denmark, involving recumbency (lying down and unable to rise) and some deaths. Most adverse events occurred within 8 to 24 hours following product administration. Anecdotal evidence suggests that hypocalcaemia treatments may be successful in reversing clinical signs.
Ceva has decided to stop further distribution of the product in Europe voluntarily, pending the outcome of further investigations to assess a possible causal link between the product and the adverse events reported.
The VMD, EMA, other agencies throughout Europe and the MAH are working closely to monitor the situation.
The VMD highlights that due to the nature and use of the product there is no risk to human health or consumer safety.
Vets and dairy farmers are strongly encouraged to report any adverse events associated with use of Velactis to the VMD using its online reporting form or directly to Ceva for further investigation by the MAH as necessary.
Dr Pete Down, Associate Dean for Undergraduate Education in UCLan’s School of Veterinary Medicine, said: “We recognise the multifaceted challenges the profession is facing at the moment, but many of us have spent significant time out in practice and recognise that it can be a fantastic career.
“Additionally, first-opinion vets provide essential services to the pet-owning public, equine, and farming industries.
"Our curriculum focusses on the provision of contextual-care and encourages vet students to see general practice as a fantastic career in and of itself.
"Also, whilst diversity in the profession has traditionally been a challenge, our student recruitment practices support an inclusive approach, recruiting students from a wide variety of backgrounds.”
The practically focused curriculum is ‘hands-on’ from year one and the university says it uses innovative digital technologies from the outset: its students will be among the first in the country to use specialist Anatomage vet tables.
Dr Heather Bacon OBE, Dean of UCLan’s School of Veterinary Medicine, said: “It’s a landmark day for the University as we’ve welcomed our first cohort of veterinary medicine students through the door.
"The demand for places on the first year of our BVMS course was huge and I’m thrilled we’ve been able to enrol so many enthusiastic student vets on to our programme.”
https://www.uclan.ac.uk/undergraduate/courses/veterinary-medicine-surgery-bvms
According to the BVA’s Voice of the Veterinary Profession survey, 9 out of 10 companion animal veterinary surgeons report that the number of brachycephalic dogs being brought into their practice has greatly increased over the past three years.
98% said they had treated brachycephalic dogs for conformation-related health problems in the past year, and that 56% of the brachycephalic dogs being brought into practice either had, or would have benefited from having treatment for conformation-related health and welfare problems.
49% of UK vets say that the high profile of brachycephalic breeds in social media and advertising is one of the main reasons that clients choose to get a brachycephalic pet.
The #breedtobreathe campaign includes a number of things designed to tackle the problem. Firstly, practices are urged not to use images of brachycephalic dogs in their own marketing materials and communications. In addition the BVA has prepared a toolbox with a template letter for you to send to companies and brands that use brachycephalic breeds in their advertising, together with a range of images and a video you can share on social media, such as Facebook.
BVA President John Fishwick said: "Several well-known brands that use images of flat-faced dogs, such as Costa Coffee, Heinz and Comic Relief, have responded positively to letters from BVA and individual members of the profession recently, and pledged to avoid using them in future campaigns. These seemingly small victories offer hope for greater and long-lasting change.
"While the veterinary profession is relatively small, its reach is significant and its role is critical to the health and welfare of not only animals, but the rest of society too. That is why we believe that it is important for the veterinary team to utilise its spheres of influence both online and offline, which includes avoiding mixed messages between what clients and the wider public are being told by vets and VNs in practice and what they were seeing in practice communications.
"We’re urging vets to continue speaking out on behalf of the animals that we swear an oath to protect, since we know that hearing first-hand from individual members of the vet-led team has a real impact on the brands in question. BVA will continue to support members in challenging irresponsible promotions using these breeds."
The BVA has drawn up a position statement which lists ten actions that veterinary practices can undertake to improve brachycephalic breeds’ health and welfare and promote responsible ownership:
For more information, visit: www.bva.co.uk/brachys.
Photo: ponpimonsa_bibi/Shutterstock
Dr Corsi consulted with Kika's owners about the management of her pregnancy at the end of November 2017, finding at least 4 puppies on an x-ray taken at the time.
The first of five charges against Dr Corsi was that on the 14th December, after being advised by Kika's owners that the dog had produced two live puppies and one dead puppy the previous night, she failed to advise them that Kika needed an immediate veterinary examination.
The second charge was that, having been telephoned for a second time by the owner, she still failed to advise the owners that Kika required an immediate veterinary examination.
The third charge was that, following an examination of Kika that afternoon, and having ascertained that Kika required a caesarean section to remove one undelivered puppy, Dr Corsi failed to perform the caesarean section that day and advised the owner that Kika could undergo the caesarean section (at the practice, performed by her) the next day (or words to the effect).
The charge also stated that she failed to advise the owner that Kika’s health and welfare required the caesarean section to be performed that day; and that she failed to advise them that, if she or another veterinary surgeon at the practice could not perform the surgery that day, Kika needed to be referred to the out-of-hours clinic so that the caesarean section could take place on the 14th December.
The fourth charge was that Dr Corsi failed to recognise that Kika’s health and welfare required a caesarean section to be performed on 14th December.
The fifth charge was that, on 16th December 2017, having been telephoned by the owner at about 5pm and having been informed that Kika was weak and had not been eating post-operatively, Dr Corsi failed to advise the owner that Kika should be presented urgently for a veterinary examination.
The Disciplinary Committee considered the facts of the case and heard evidence from a number of witnesses including the owners of Kika and Dr Corsi, and from Mr Maltman MRCVS who was called as an expert witness on behalf of the College and Mr Chitty, who was called as an expert witness on behalf of Dr Corsi.
Having considered all of the evidence, the Committee found all aspects of the first and second charges proven in their entirety.
The Committee found the majority of the third charge not proved, with the exception of the fact that it found that Dr Corsi did advise the owner that she could undertake the Caesarean section on 15 December 2017.
In light of the Committee’s findings in respect of the aspects of charge three that were not proved, charge four was also found not proved.
Finally, the Committee considered that charge five was found not proved.
The Committee then went on to consider whether the charges that were found proven amounted to serious professional misconduct either individually and/or cumulatively.
Committee Chair Cerys Jones said: "In light of the evidence of both parties’ experts, the Committee was of the view that there was a risk of harm or injury resulting from Dr Corsi’s failure - the Committee decided that this was an aggravating factor.
"However, the Committee took into account that, at the time of both calls, Dr Corsi had a rationale for her decision, that she asked appropriate questions and received answers which led her to make what she considered to be a reasoned assessment.
"She had also made arrangements in both calls to be kept updated either at a pre-arranged time or sooner if Kika’s condition changed. On this basis, the Committee was satisfied that, while this was an error of judgement, it did not fall so far short of what was expected as to amount to disgraceful conduct."
Therefore, the Committee decided that while Dr Corsi’s conduct in Charges 1 and 2 demonstrated a departure from professional standards, the falling short was not so grave as to amount to disgraceful conduct in a professional respect.
The full decision can be read here: https://www.rcvs.org.uk/concerns/disciplinary-hearings/
Jonathan Hill (UK Country Manager) said: “I’m delighted to announce that TVM UK is changing its name to Dômes Pharma.
"This will align with the other operating companies within the group.
"TVM UK has always been owned by the Dômes Pharma group, and since the start of our journey in the UK market we have been synonymous with expertise and outstanding levels of customer service in selected speciality segments of the animal health market and this won’t change.”
“Under the Dômes Pharma name we will continue to build and grow on this very strong foundation.
"I’m looking forward to working with the entire Dômes Pharma team as we increase our presence as a leading specialty pharmaceutical company, bringing our ethos to new speciality segments with innovative products and solutions for vets in the UK.
"Dômes Pharma remains a family-owned business, and the culture of the company really reflects this and we live by our values of kindness, boldness and responsibility.” https://www.domespharma.com https://www.tvm-uk.com